# EDGAR Filing Document

**Accession Number:** 0001955728
**File Stem:** 0001955728-26-000006
**Filing Date:** 2026-6
**Character Count:** 3117
**Document Hash:** 643aa63f44fc85f9a691748baffea1e3
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001955728-26-000006.hdr.sgml**: 20260601

**ACCESSION NUMBER**: 0001955728-26-000006

**CONFORMED SUBMISSION TYPE**: C-AR

**CONFIRMING COPY**: 

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20251231

**FILED AS OF DATE**: 20260601

**DATE AS OF CHANGE**: 20260529

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** ACESIS HOLDINGS CORP.
- **CENTRAL INDEX KEY:** 0001955728
- **STANDARD INDUSTRIAL CLASSIFICATION:** BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 884251528
- **STATE OF INCORPORATION:** NV
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** C-AR
- **SEC ACT:** 1933 Act
- **SEC FILE NUMBER:** 020-35674

**BUSINESS ADDRESS:**
- **STREET 1:** 8085 S CHESTER STREET
- **STREET 2:** SUITE 250
- **CITY:** CENTENNIAL
- **STATE:** CO
- **ZIP:** 80112
- **BUSINESS PHONE:** 720-389-0650

**MAIL ADDRESS:**
- **STREET 1:** 8085 S. CHESTER STREET
- **STREET 2:** STE 250
- **CITY:** CENTENNIAL
- **STATE:** CO

### Attached PDF Documents

**Attachment 1:** `formc-ar.pdf`

_No text found in this document._

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM C

### UNDER THE SECURITIES ACT OF 1933

### Issuer Information

**Name of Issuer:** Acesis Holdings Corporation

**Legal Status:** Corporation

**Jurisdiction of Incorporation/Organization:** NV

**Date of Organization:** 10-06-2022

**Physical Address:** 8085 S. Chester Street, Centennial, CO, 80112

**Issuer Website:** https://acesisbio.com

**Is there a Co-Issuer?:** No

### Offering Information

**Oversubscription Accepted:** No

### Annual Report Disclosure Requirements

**Current Number of Employees:** 2

**Total Assets (Most Recent Fiscal Year):** $152,090.00

**Total Assets (Prior Fiscal Year):** $760,598.00

**Cash & Cash Equivalents (Most Recent Fiscal Year):** $142,440.00

**Cash & Cash Equivalents (Prior Fiscal Year):** $623,293.00

**Accounts Receivable (Most Recent Fiscal Year):** $0.00

**Accounts Receivable (Prior Fiscal Year):** $0.00

**Short-Term Debt (Most Recent Fiscal Year):** $1,321,796.00

**Short-Term Debt (Prior Fiscal Year):** $1,161,788.00

**Long-Term Debt (Most Recent Fiscal Year):** $0.00

**Long-Term Debt (Prior Fiscal Year):** $0.00

**Revenues/Sales (Most Recent Fiscal Year):** $0.00

**Revenues/Sales (Prior Fiscal Year):** $0.00

**Cost of Goods Sold (Most Recent Fiscal Year):** $0.00

**Cost of Goods Sold (Prior Fiscal Year):** $0.00

**Taxes Paid (Most Recent Fiscal Year):** $0.00

**Taxes Paid (Prior Fiscal Year):** $0.00

**Net Income (Most Recent Fiscal Year):** $-2,091,489.00

**Net Income (Prior Fiscal Year):** $-1,499,932.00

### Signatures

**Issuer:** Acesis Holdings Corporation

**Signature:** Konstantinos (Costas) Karatzas

**Title:** CEO

---

**Signature:** Konstantinos (Costas) Karatzas

**Title:** CEO

**Date:** 05-29-2026

---

**Signature:** Vassilios Papadopoulos

**Title:** Director

**Date:** 05-29-2026

---

**Signature:** Frederic Fasano

**Title:** Director

**Date:** 05-29-2026